Journal for ImmunoTherapy of Cancer
Journal for ImmunoTherapy of Cancer is an open-access journal published by BMJ in the United Kingdom. OpenAlex counts 15,029 works from it, cited 248,494 times; its h-index is 196. Its two-year mean citedness, which is computed the way the impact factor is, is 2.87: a paper it published in the two years before was cited about 2.87 times last year. It published 2,036 papers in 2025, about as many as in 2024. Its article processing charge is about US$2,490.
- Publisher
- BMJ
- Citations per paper
- 2.87 two-year mean, OpenAlex
- h-index
- 196 i10-index 3,581
- Access
- Open access · in DOAJ
- APC
- US$2,490
- ISSN
- 2051-1426
- Country
- United Kingdom
- Works published
- 15,029 cited 248,494 times
- Papers in 2025
- 2,036
- Field
- Medicine
- Website
- Journal home ↗
Journal for ImmunoTherapy of Cancer year by year
Papers it published each year, and the citations all its papers received that year.
| Year | Papers published | Citations received |
|---|---|---|
| 2026 so far | 1,730 | 47,029 |
| 2025 | 2,036 | 46,018 |
| 2024 | 1,969 | 40,348 |
| 2023 | 2,065 | 34,576 |
| 2022 | 2,087 | 29,716 |
| 2021 | 1,610 | 22,214 |
| 2020 | 1,521 | 13,453 |
| 2019 | 369 | 6,224 |
What Journal for ImmunoTherapy of Cancer publishes
Its most frequent research topics, by OpenAlex's topic classification.
- Cancer Immunotherapy and BiomarkersOncology · 11,144 papers
- Immunotherapy and Immune ResponsesImmunology · 7,273 papers
- T-cell and B-cell ImmunologyImmunology · 3,357 papers
- CAR-T cell therapy researchOncology · 2,458 papers
- Monoclonal and Polyclonal Antibodies ResearchImmunology · 1,260 papers
Questions about Journal for ImmunoTherapy of Cancer
What is the impact factor of Journal for ImmunoTherapy of Cancer?
Clarivate's Journal Impact Factor is licensed and not shown here. OpenAlex's two-year mean citedness, computed the same way from open data, is 2.87 for Journal for ImmunoTherapy of Cancer: on average, each paper it published in the two years before was cited about 2.87 times in a year.
What is the h-index of Journal for ImmunoTherapy of Cancer?
196, by OpenAlex's count: 196 of its papers have each been cited at least 196 times. Its i10-index is 3,581.
Is Journal for ImmunoTherapy of Cancer open access?
Yes. OpenAlex lists Journal for ImmunoTherapy of Cancer as an open-access journal: its papers are free to read. It is also listed in the Directory of Open Access Journals (DOAJ).
What is the publication fee (APC) of Journal for ImmunoTherapy of Cancer?
About US$2,490, which is its article processing charge (APC) as listed by OpenAlex. Fees change and waivers exist, so check the journal's own page before you submit.
What is the ISSN of Journal for ImmunoTherapy of Cancer?
Its linking ISSN is 2051-1426.
Who publishes Journal for ImmunoTherapy of Cancer?
BMJ, based in the United Kingdom.
How many papers does Journal for ImmunoTherapy of Cancer publish a year?
2,036 in 2025, by OpenAlex's count of what it published that year.
What does Journal for ImmunoTherapy of Cancer publish?
Its most frequent research topics are Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, T-cell and B-cell Immunology, in the field of Medicine.
Is Journal for ImmunoTherapy of Cancer a predatory journal?
Nothing in the scholarly indexes suggests so. Journal for ImmunoTherapy of Cancer is on OpenAlex's list of core sources, journals with peer review and an editorial board, it has published 15,029 works cited 248,494 times, and it is listed in DOAJ. For a journal you do not know, check the red flags with our predatory journal checker.
Is Journal for ImmunoTherapy of Cancer indexed in Scopus or Web of Science?
Check the Scopus Sources list and Clarivate's Master Journal List by its ISSN (2051-1426): both are free to search. Our guide on checking journal indexing shows each step.
Journals like Journal for ImmunoTherapy of Cancer
Other Medicine journals with a similar impact.
Journal data from OpenAlex (CC0), compiled 21 November 2026. Download the whole directory as a CSV file (CC BY 4.0).